Antipsychotic medication for women with schizophrenia spectrum disorders (vol 52, pg 649, 2022)

被引：1
|
作者：
Brand, Bodyl A. [1 ]
Haveman, Yudith R. A. [1 ]
de Beer, Franciska [1 ]
de Boer, Janna N. [1 ,2 ]
Dazzan, Paola [3 ,4 ,5 ]
Sommer, Iris E. C. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Sect Cognit Neurosci, Groningen, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Psychiat, Utrecht, Netherlands
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England
[4] South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res NIHR Mental Hlth Biomed Res Ctr, London, England
[5] Kings Coll London, London, England
来源：
PSYCHOLOGICAL MEDICINE | 2023年 / 53卷 / 10期
关键词：
D O I：
10.1017/S0033291723001344
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
[No abstract available]
引用
收藏
页码：4832 / 4832
页数：1
相关论文
共 50 条
  • [1] Antipsychotic medication for women with schizophrenia spectrum disorders
    Brand, Bodyl A.
    Haveman, Yudith R. A.
    de Beer, Franciska
    de Boer, Janna N.
    Dazzan, Paola
    Sommer, Iris E. C.
    PSYCHOLOGICAL MEDICINE, 2022, 52 (04) : 649 - 663
  • [2] A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
    Sendt, Kyra-Verena
    Tracy, Derek Kenneth
    Bhattacharyya, Sagnik
    PSYCHIATRY RESEARCH, 2015, 225 (1-2) : 14 - 30
  • [3] COGNITIVE THERAPY FOR PEOPLE WITH SCHIZOPHRENIA SPECTRUM DISORDERS NOT TAKING ANTIPSYCHOTIC MEDICATION: A RANDOMISED CONTROLLED TRIAL
    Morrison, Anthony P.
    Turkington, Douglas
    Pyle, Melissa
    Spencer, Helen
    Brabban, Alison
    Dunn, Graham
    Christodoulides, Tom
    Dudley, Rob
    Chapman, Nicola
    Hutton, Paul
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S75 - S75
  • [4] Interaction Between Neurological Soft Signs, Extrapyramidal MotorSymptoms and Antipsychotic Medication in Schizophrenia Spectrum Disorders
    Hirjak, Dusan
    Fritze, Stefan
    Sambataro, Fabio
    Bertolino, Alina
    Topor, Cristina
    Kubera, Katharina
    Wolf, Robert Christian
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S181 - S181
  • [5] Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders
    Gao, Y. Nina
    Wang, Rui
    Gu, Gyojeong
    Chung, Rakkoo
    Olfson, Mark
    SCHIZOPHRENIA RESEARCH, 2024, 267 : 165 - 172
  • [6] The Lived Experience of the Women with Schizophrenia Taking Antipsychotic Medication
    Song, Eun-Ju
    JOURNAL OF KOREAN ACADEMY OF NURSING, 2011, 41 (03) : 382 - 392
  • [7] Efficacy of atypical antipsychotic drugs for delusions in schizophrenia spectrum disorders
    Nakanishi, Shinsuke
    Takahashi, Toshihiko
    Kunugi, Hiroshi
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A17 - A17
  • [8] Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders (Vol 25, Pg 723, 2023)
    Brand, Bodyl A.
    Willemse, Elske J. M.
    Hamers, Iris M. H.
    Sommer, Iris E.
    CURRENT PSYCHIATRY REPORTS, 2024, 26 (10) : 550 - 551
  • [9] PSYCHOPATHOLOGICAL PREDICTORS OF ANTIPSYCHOTIC MEDICATION USE IN CHILDHOOD AUTISM SPECTRUM DISORDERS
    Downs, J.
    Hotopf, M.
    Jackson, R. G.
    Shetty, H.
    Ford, T.
    Stewart, R.
    Hayes, R. D.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [10] Antipsychotic medication during pregnancy and lactation in women with schizophrenia: Evaluating the risk
    Patton, SW
    Misri, S
    Corral, MR
    Perry, KF
    Kuan, AJ
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (10): : 959 - 965
12345